Follow

'Risks associated with AI systems can vary widely and depend on the severity of the medical condition it is designed for, how its output is used to inform care, the patient population it is intended to be used in, and the existing level of evidence for the system3. Risk determination, and therefore whether an informed consent waiver is appropriate, will need to be on a case-by-case basis for trials of AI systems.'

nature.com/articles/s41591-023

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.